サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1360320

経皮皮膚パッチ市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年

Transdermal Skin Patches Market (Product Type: Reservoir, Drug-in-Adhesive, Matrix, Microneedle, and Others; and Sales Type: Prescription and Over-the-Counter [OTC]) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 186 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
経皮皮膚パッチ市場：世界の業界分析、規模、シェア、成長、動向、および予測、2023年から2031年
出版日: 2023年08月30日
発行: Transparency Market Research
ページ情報: 英文 186 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経皮皮膚パッチ市場- レポートの範囲

世界の経皮皮膚パッチ市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、世界の経皮皮膚パッチの収益を提供します。 2023年を基準年、2031年を予測年とみなして、2017年から2031年の期間の市場を分析します。レポートは、2023年から2031年までの世界の経皮皮膚パッチ市場の年間平均成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、経皮皮膚パッチ市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値 77億米ドル
2031年の市場価値 115億米ドル
CAGR 4.6%

このレポートは、世界の経皮皮膚パッチ市場の競合情勢を詳しく掘り下げています。世界の経皮皮膚パッチ市場で活動する主要企業が特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の経皮皮膚パッチ市場のプレーヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017～2031年

第5章 主要な洞察

  • 地域/世界ごとの規制シナリオ
  • 主要国の世界の病気の有病率と罹患率
  • パイプライン分析
  • 主要製品/ブランド分析
  • COVID-19による業界への影響

第6章 世界市場の分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な発見と開発
  • 製品タイプ別の市場価値予測、2017～2031年
    • 貯水池
    • 接着剤中の薬物
      • 単層
      • 多層
    • マイクロニードル
    • マトリックス
    • その他（蒸気等）
  • 製品タイプ別の市場魅力度

第7章 世界市場の分析と予測：用途別

  • イントロダクションと定義
  • 主な発見と開発
  • 用途別の市場価値予測、2017～2031年
    • 疼痛管理
    • ホルモン障害
    • 禁煙と禁煙補助
    • 神経学的障害
    • 心血管疾患
    • その他（乗り物酔い、過活動膀胱など）
  • 用途別の市場の魅力

第8章 世界市場の分析と予測：売上タイプ別

  • イントロダクションと定義
  • 主な発見と開発
  • 売上タイプ別の市場価値予測、2017～2031年
    • 処方箋
    • 店頭販売（OTC）
  • 売上タイプ別の市場魅力度

第9章 世界市場の分析と予測：流通チャネル別

  • イントロダクションと定義
  • 主な発見と開発
  • 流通チャネル別の市場価値予測、2017～2031年
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 流通チャネル別の市場魅力度

第10章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 地域別の市場価値予測
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別の市場魅力度

第11章 北米市場の分析と予測

第12章 欧州市場の分析と予測

第13章 アジア太平洋市場の分析と予測

第14章 ラテンアメリカ市場の分析と予測

第15章 中東およびアフリカ市場の分析と予測

第16章 競合情勢

  • 市場企業- 競合マトリックス（企業の階層および規模別）
  • 企業別市場シェア分析（2022）
  • 企業プロファイル
    • Hisamitsu Pharmaceutical Co., Inc.
    • Viatris Inc.
    • Nitto Denko Corporation
    • Novartis AG
    • Luye Pharma Group
    • Teikoku Pharma
    • Samyang Holdings Corporation
    • Gedeon Richter PLC
    • AdhexPharma
    • Sparsha Pharma International Pvt. Ltd.
図表

List of Tables

  • Table 1. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 2. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 3. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 4. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 5. Global Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
  • Table 6. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 7. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 8. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 9. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 10. North America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
  • Table 11. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 12. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 13. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 14. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 15. Europe Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
  • Table 16. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 17. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 18. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 19. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 20. Asia Pacific Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
  • Table 21. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 22. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 23. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 24. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 25. Latin America Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031
  • Table 26. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Product Type, 2017-2031
  • Table 27. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Application, 2017-2031
  • Table 28. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Sales Type, 2017-2031
  • Table 29. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 30. Middle East & Africa Transdermal Skin Patches Market Size (US$ Bn) Forecast, by Region, 2017-2031

List of Figures

  • Figure 1. Global Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 2. Global Transdermal Skin Patches Market Value Share by Product Type, 2017-2031
  • Figure 3. Global Transdermal Skin Patches Market Value Share by Application, 2017-2031
  • Figure 4. Global Transdermal Skin Patches Market Value Share by Sales Type, 2017-2031
  • Figure 5. Global Transdermal Skin Patches Market Value Share by Distribution Channel, 2017-2031
  • Figure 6. Global Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 7. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Reservoir, 2017-2031
  • Figure 8. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Drug-in-Adhesive, 2017-2031
  • Figure 9. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Microneedle, 2017-2031
  • Figure 10. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Matrix, 2017-2031
  • Figure 11. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Others, 2017-2031
  • Figure 12. Global Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 13. Global Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 14. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Pain Management, 2017-2031
  • Figure 15. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Hormonal Disorders, 2017-2031
  • Figure 16. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Smoking Reduction and Cessation Aid, 2017-2031
  • Figure 17. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Neurological Disorders, 2017-2031
  • Figure 18. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Cardiovascular Disorders, 2017-2031
  • Figure 19. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Others, 2017-2031
  • Figure 20. Global Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
  • Figure 21. Global Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 22. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Prescription, 2017-2031
  • Figure 23. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Over-the-Counter (OTC), 2017-2031
  • Figure 24. Global Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
  • Figure 25. Global Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022 and 2031
  • Figure 26. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Hospital Pharmacies, 2017-2031
  • Figure 27. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Retail Pharmacies, 2017-2031
  • Figure 28. Global Transdermal Skin Patches Market Revenue (US$ Bn) by Online Pharmacies, 2017-2031
  • Figure 29. Global Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
  • Figure 30. Global Transdermal Skin Patches Market Value Share Analysis by Region, 2022 and 2031
  • Figure 31. Global Transdermal Skin Patches Market Attractiveness Analysis by Region, 2023-2031
  • Figure 32. North America Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 33. North America Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
  • Figure 34. North America Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
  • Figure 35. North America Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 36. North America Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 37. North America Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 38. North America Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
  • Figure 39. North America Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 40. North America Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
  • Figure 41. North America Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022 and 2031
  • Figure 42. North America Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
  • Figure 43. Europe Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 44. Europe Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
  • Figure 45. Europe Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
  • Figure 46. Europe Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 47. Europe Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 48. Europe Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 49. Europe Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
  • Figure 50. Europe Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 51. Europe Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
  • Figure 52. Europe Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022 and 2031
  • Figure 53. Europe Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
  • Figure 54. Asia Pacific Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 55. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
  • Figure 56. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
  • Figure 57. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 58. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 59. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 60. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
  • Figure 61. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 62. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2023-2031
  • Figure 63. Asia Pacific Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022-2031
  • Figure 64. Asia Pacific Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
  • Figure 65. Latin America Transdermal Skin Patches Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 66. Latin America Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
  • Figure 67. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Country, 2023-2031
  • Figure 68. Latin America Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 69. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Product Type, 2023-2031
  • Figure 70. Latin America Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 71. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Application, 2023-2031
  • Figure 72. Latin America Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 73. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Sales Type, 2022-2031
  • Figure 74. Latin America Transdermal Skin Patches Market Value Share Analysis by Distribution Channel, 2022-2031
  • Figure 75. Latin America Transdermal Skin Patches Market Attractiveness Analysis by Distribution Channel, 2023-2031
  • Figure 76. Middle East & Africa Transdermal Skin Patches Market Value (US$ Bn), 2017-2031
  • Figure 77. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Country, 2022 and 2031
  • Figure 78. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Country, 2023-2031
  • Figure 79. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Product Type, 2022 and 2031
  • Figure 80. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Product Type, 2023-2031
  • Figure 81. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Application, 2022 and 2031
  • Figure 82. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Application, 2023-2031
  • Figure 83. Middle East & Africa Transdermal Skin Patches Market Value Share Analysis by Sales Type, 2022 and 2031
  • Figure 84. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Sales Type, 2023-2031
  • Figure 85. Middle East & Africa Transdermal Skin Patches Market Value Share by Distribution Channel, 2022 and 2031
  • Figure 86. Middle East & Africa Transdermal Skin Patches Market Attractiveness by Distribution Channel, 2023-2031
  • Figure 87. Company Share Analysis Transdermal Skin Patches, 2022
目次
Product Code: TMRGL2245

Transdermal Skin Patches Market - Scope of Report

TMR's report on the global transdermal skin patches market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global transdermal skin patches market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global transdermal skin patches market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the transdermal skin patches market.

Market Snapshot
Market Value in 2023US$ 7.7 Bn
Market Value in 2031US$ 11.5 Bn
CAGR4.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global transdermal skin patches market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global transdermal skin patches market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global transdermal skin patches market.

The report delves into the competitive landscape of the global transdermal skin patches market. Key players operating in the global transdermal skin patches market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global transdermal skin patches market profiled in this report.

Key Questions Answered in Global Transdermal Skin Patches Market Report:

  • What is the sales/revenue generated by transdermal skin patches across all regions during the forecast period?
  • What are the opportunities in the global transdermal skin patches market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Transdermal Skin Patches Market - Research Objectives and Research Approach

The comprehensive report on the global transdermal skin patches market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global transdermal skin patches market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global transdermal skin patches market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transdermal Skin Patches Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Transdermal Skin Patches Market Analysis and Forecast, 2017 - 2031
    • 4.4.1. Market Revenue Projection (US$ Bn)

5. Key Insights

  • 5.1. Regulatory Scenario by Region/Globally
  • 5.2. Disease Prevalence & Incidence Rate Globally with Key Countries
  • 5.3. Pipeline Analysis
  • 5.4. Key Product/brand Analysis
  • 5.5. COVID-19 Impact on the Industry

6. Global Transdermal Skin Patches Market Analysis and Forecast, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2017 - 2031
    • 6.3.1. Reservoir
    • 6.3.2. Drug-in-Adhesive
      • 6.3.2.1. Single Layer
      • 6.3.2.2. Multilayer
    • 6.3.3. Microneedle
    • 6.3.4. Matrix
    • 6.3.5. Others (Vapor, etc.)
  • 6.4. Market Attractiveness By Product Type

7. Global Transdermal Skin Patches Market Analysis and Forecast, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2017 - 2031
    • 7.3.1. Pain Management
    • 7.3.2. Hormonal Disorders
    • 7.3.3. Smoking Reduction and Cessation Aid
    • 7.3.4. Neurological Disorders
    • 7.3.5. Cardiovascular Disorders
    • 7.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 7.4. Market Attractiveness By Application

8. Global Transdermal Skin Patches Market Analysis and Forecast, By Sales Type

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Sales Type, 2017 - 2031
    • 8.3.1. Prescription
    • 8.3.2. Over-the-Counter (OTC)
  • 8.4. Market Attractiveness By Sales Type

9. Global Transdermal Skin Patches Market Analysis and Forecast, By Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Market Attractiveness By Distribution Channel

10. Global Transdermal Skin Patches Market Analysis and Forecast, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Transdermal Skin Patches Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product Type, 2017 - 2031
    • 11.2.1. Reservoir
    • 11.2.2. Drug-in-Adhesive
      • 11.2.2.1. Single Layer
      • 11.2.2.2. Multilayer
    • 11.2.3. Microneedle
    • 11.2.4. Matrix
    • 11.2.5. Others (Vapor, etc.)
  • 11.3. Market Value Forecast By Application, 2017 - 2031
    • 11.3.1. Pain Management
    • 11.3.2. Hormonal Disorders
    • 11.3.3. Smoking Reduction and Cessation Aid
    • 11.3.4. Neurological Disorders
    • 11.3.5. Cardiovascular Disorders
    • 11.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 11.4. Market Value Forecast By Sales Type, 2017 - 2031
    • 11.4.1. Prescription
    • 11.4.2. Over-the-Counter (OTC)
  • 11.5. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 11.5.1. Hospital Pharmacies
    • 11.5.2. Retail Pharmacies
    • 11.5.3. Online Pharmacies
  • 11.6. Market Value Forecast By Country, 2017 - 2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Application
    • 11.7.3. By Sales Type
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country

12. Europe Transdermal Skin Patches Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2017 - 2031
    • 12.2.1. Reservoir
    • 12.2.2. Drug-in-Adhesive
      • 12.2.2.1. Single Layer
      • 12.2.2.2. Multilayer
    • 12.2.3. Microneedle
    • 12.2.4. Matrix
    • 12.2.5. Others (Vapor, etc.)
  • 12.3. Market Value Forecast By Application, 2017 - 2031
    • 12.3.1. Pain Management
    • 12.3.2. Hormonal Disorders
    • 12.3.3. Smoking Reduction and Cessation Aid
    • 12.3.4. Neurological Disorders
    • 12.3.5. Cardiovascular Disorders
    • 12.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 12.4. Market Value Forecast By Sales Type, 2017 - 2031
    • 12.4.1. Prescription
    • 12.4.2. Over-the-Counter (OTC)
  • 12.5. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 12.5.1. Hospital Pharmacies
    • 12.5.2. Retail Pharmacies
    • 12.5.3. Online Pharmacies
  • 12.6. Market Value Forecast By Country, 2017 - 2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Application
    • 12.7.3. By Sales Type
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country

13. Asia Pacific Transdermal Skin Patches Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2017 - 2031
    • 13.2.1. Reservoir
    • 13.2.2. Drug-in-Adhesive
      • 13.2.2.1. Single Layer
      • 13.2.2.2. Multilayer
    • 13.2.3. Microneedle
    • 13.2.4. Matrix
    • 13.2.5. Others (Vapor, etc.)
  • 13.3. Market Value Forecast By Application, 2017 - 2031
    • 13.3.1. Pain Management
    • 13.3.2. Hormonal Disorders
    • 13.3.3. Smoking Reduction and Cessation Aid
    • 13.3.4. Neurological Disorders
    • 13.3.5. Cardiovascular Disorders
    • 13.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 13.4. Market Value Forecast By Sales Type, 2017 - 2031
    • 13.4.1. Prescription
    • 13.4.2. Over-the-Counter (OTC)
  • 13.5. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 13.5.1. Hospital Pharmacies
    • 13.5.2. Retail Pharmacies
    • 13.5.3. Online Pharmacies
  • 13.6. Market Value Forecast By Country, 2017 - 2031
    • 13.6.1. Japan
    • 13.6.2. China
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Application
    • 13.7.3. By Sales Type
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country

14. Latin America Transdermal Skin Patches Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2017 - 2031
    • 14.2.1. Reservoir
    • 14.2.2. Drug-in-Adhesive
      • 14.2.2.1. Single Layer
      • 14.2.2.2. Multilayer
    • 14.2.3. Microneedle
    • 14.2.4. Matrix
    • 14.2.5. Others (Vapor, etc.)
  • 14.3. Market Value Forecast By Application, 2017 - 2031
    • 14.3.1. Pain Management
    • 14.3.2. Hormonal Disorders
    • 14.3.3. Smoking Reduction and Cessation Aid
    • 14.3.4. Neurological Disorders
    • 14.3.5. Cardiovascular Disorders
    • 14.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 14.4. Market Value Forecast By Sales Type, 2017 - 2031
    • 14.4.1. Prescription
    • 14.4.2. Over-the-Counter (OTC)
  • 14.5. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 14.5.1. Hospital Pharmacies
    • 14.5.2. Retail Pharmacies
    • 14.5.3. Online Pharmacies
  • 14.6. Market Value Forecast By Country, 2017 - 2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Application
    • 14.7.3. By Sales Type
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country

15. Middle East & Africa Transdermal Skin Patches Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Product Type, 2017 - 2031
    • 15.2.1. Reservoir
    • 15.2.2. Drug-in-Adhesive
      • 15.2.2.1. Single Layer
      • 15.2.2.2. Multilayer
    • 15.2.3. Microneedle
    • 15.2.4. Matrix
    • 15.2.5. Others (Vapor, etc.)
  • 15.3. Market Value Forecast By Application, 2017 - 2031
    • 15.3.1. Pain Management
    • 15.3.2. Hormonal Disorders
    • 15.3.3. Smoking Reduction and Cessation Aid
    • 15.3.4. Neurological Disorders
    • 15.3.5. Cardiovascular Disorders
    • 15.3.6. Others (Motion Sickness, Overactive Bladder, etc.)
  • 15.4. Market Value Forecast By Sales Type, 2017 - 2031
    • 15.4.1. Prescription
    • 15.4.2. Over-the-Counter (OTC)
  • 15.5. Market Value Forecast By Distribution Channel, 2017 - 2031
    • 15.5.1. Hospital Pharmacies
    • 15.5.2. Retail Pharmacies
    • 15.5.3. Online Pharmacies
  • 15.6. Market Value Forecast By Country, 2017 - 2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of the Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product Type
    • 15.7.2. By Application
    • 15.7.3. By Sales Type
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Hisamitsu Pharmaceutical Co., Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Viatris Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Nitto Denko Corporation
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Novartis AG
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Luye Pharma Group
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Teikoku Pharma
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Samyang Holdings Corporation
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Gedeon Richter PLC
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. AdhexPharma
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Sparsha Pharma International Pvt. Ltd.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview